We are live on ! Find out more
DOVA

Dova Pharmaceuticals, Inc. Common Stock
DOVA

Delisted

DOVA was delisted on the 11th of November, 2019.

Back to rankings

30 hedge funds and large institutions have $135M invested in Dova Pharmaceuticals, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+30
Holders Change %
–
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$41.5M
2
PA
Perceptive Advisors
New York
+$35.9M
3
FI
Fosun International
China
+$13.7M
4
PC
Paulson & Co
New York
+$13.1M
5
Wells Fargo
Wells Fargo
California
+$4.21M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$44M +$41.5M +1,972,613 New
PA
2
Perceptive Advisors
New York
$38M +$35.9M +1,706,499 New
FI
3
Fosun International
China
$14.5M +$13.7M +650,000 New
PC
4
Paulson & Co
New York
$13.9M +$13.1M +621,632 New
Wells Fargo
5
Wells Fargo
California
$4.46M +$4.21M +200,000 New
NC
6
Nexthera Capital
New York
$4.42M +$4.17M +198,059 New
MIM
7
Monashee Investment Management
Massachusetts
$2.23M +$2.1M +100,000 New
SFM
8
Sphera Funds Management
Israel
$2.12M +$2M +95,000 New
PWAM
9
Park West Asset Management
California
$1.34M +$1.26M +60,000 New
Millennium Management
10
Millennium Management
New York
$1.21M +$1.14M +54,365 New
PC
11
Pier Capital
Connecticut
$1.19M +$1.12M +53,426 New
CI
12
Conning Inc
Connecticut
$1.11M +$1.05M +50,000 New
OA
13
Omega Advisors
New York
$892K +$842K +40,000 New
Alyeska Investment Group
14
Alyeska Investment Group
Illinois
$780K +$737K +35,000 New
Tudor Investment Corp
15
Tudor Investment Corp
Connecticut
$699K +$660K +31,345 New
Ameriprise
16
Ameriprise
Minnesota
$668K +$631K +29,969 New
WAM
17
Wolverine Asset Management
Illinois
$557K +$526K +25,000 New
Goldman Sachs
18
Goldman Sachs
New York
$493K +$465K +22,100 New
Norges Bank
19
Norges Bank
Norway
$390K +$368K +17,500 New
Vanguard Group
20
Vanguard Group
Pennsylvania
$390K +$368K +17,500 New
JP Morgan Chase
21
JP Morgan Chase
New York
$382K +$361K +17,135 New
Wellington Management Group
22
Wellington Management Group
Massachusetts
$313K +$296K +14,063 New
HCM
23
Highbridge Capital Management
New York
$260K +$246K +11,667 New
LCM
24
Laurion Capital Management
New York
$223K +$211K +10,000 New
Point72 Asset Management
25
Point72 Asset Management
Connecticut
$223K +$211K +10,000 New
1
2

DOVA Hedge Fund Activity: Q2 2017 in Review

30 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Dova Pharmaceuticals, Inc. Common Stock (DOVA) for Q2 2017, worth a combined $135M.

Buyers outnumbered sellers: 30 funds opened new DOVA positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $41.5M.

  • 30 institutional investors held Dova Pharmaceuticals, Inc. Common Stock (DOVA) as of Q2 2017, up from 0 in Q1 2017.
  • Funds reported $135M of Dova Pharmaceuticals, Inc. Common Stock stock for Q2 2017.
  • 30 funds opened new Dova Pharmaceuticals, Inc. Common Stock positions in Q2 2017 and 0 closed out, a net change of +30 holders.
  • The largest Dova Pharmaceuticals, Inc. Common Stock buyer in Q2 2017 was Fidelity Investments, an estimated $41.5M added.

Based on aggregated 13F filings for Q2 2017.